South Korean Veterinary Medicines Suppliers and Manufacturers

PRODUCTS: Korean Red Ginseng Extract Age Range (Description): 6 years Diet Type: Plant Based Material Feature: Natural Stick-type, easy way to take Korean red ginseng Ideal mix of 6-year-old Korean red ginseng and Korean traditional ingredients Health functional food: boost immune systems, relieve fatigue, improve memory, increase blood flow and help antioxidant effects Manufactured in reliable facilities: GMP, GAP

Vitamin C Drink(+ Taurine) Vitamin C is important for a normal energy-yielding metabolism and helps to reduce tiredness and fatigue together with the TAURINE. Health, Energy and/or Vitamin drinks are very popular here in South Korea and therefore is stands to reason that there would be a wide range of different options. When it comes to Vitamin C drinks, it is the market leader. Itâ??s names relates to the amount of Vitamin-C it contains and as you might expect it tastes like a sugary/medicinal mix. It can be found at basically any supermarket, mart or convenience store here in Korea. Vitamin C Function: Why do I feel energized after taking vitamin C? In addition to this, vitamin C also benefits our energy levels by maintaining and supporting energy production. How, you ask? Vitamin C works closely with the mitochondria, the part of the cell that produces energy. Does vitamin C help with energy? Reduces tiredness and fatigue Weakness and fatigue are among the symptoms of a vitamin C deficiency, so it's important to make sure you're getting enough. A cause and effect relationship has been established between the intake of adequate levels of vitamin C and reduced tiredness and fatigue.

Product Description : Red Ginseng Royal Gold Country of origin : Korea Main ingredients : red ginseng concentrate(more than 70mg/g of saponin, solid, homemade), crude royal jelly, propolis, vitamin C, honey, and oligosaccharide, etc. Specification 20m2 x 10(Vial) (200ml) Expiration date : 2 years Product summary : This product is the one reinforcing crude royal jelly and propolis, etc. which are helpful in improving the level of immunity with Korea's special product-Goryeo Red Ginseng as a main ingredient. Intake and Caution : Users are requested to take it 2-3 times a day by shaking one bottle(20ml) for one- time dosage.. (Those who are under 10 of age are supposed to take one third of the quantity for an adult and those who are under 15 of age are supposed to take a half of the quantity for an adult.) On and off, there might be a sediment in the product, but it doesn't have any relation to any abnormality in the product: thus, please shake it before taking with an easy mind.

Red Ginseng

Product Description : Korean Red Ginseng Candy Country of origin : Korea Main ingredients : red ginseng extract (red ginseng ingredient: 70mg/g or more, solid, Korea), white sugar, ion starch syrup, herb, fragrance L-menthol, etc. Specification : 320g Content per carton : 80(bags)/BOX Expiration date : 2 years Product summary : Red ginseng extract is added to everyone's favorite candy for continuous supply of red ginseng ingredients. This product is enjoyable by men and women of all ages. Intake and Caution : - Take adequate quantity any time and anywhere without upper or lower (limits.) - Unique red ginseng flavor is ideal for breath freshener after meal or easing boredom. - Those who have weak teeth are recommended to melt it slowly in the Care needs to be taken for infants not to swallow it. (mouth.)

The active ingredients of red ginseng are extracted without minimal loss, and the active ingredients are kept at low temperatures. Concentrate and put in a bottle to fully enjoy the rich taste and ingredients of red ginseng. standard : 50g, 50g x 3 bottles, 100g, 240g, etc. Main raw material : Red ginseng concentrate (6-year-old, Korea) 100%

Korean ginseng

PC-PASS Protein Characterization Analysis Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment

Biomarker Diseases Diagnosis Blood Tests Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Advantages of proteomics-based early diagnosis: Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.

Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Early diagnostic solutions BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.

PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS). Bertis developed the PASS solution based on its pan-omics, bioinformatics, and artificial intelligence (AI) technologies. We provide a variety of analyzes for proteomic analysis, biomarker discovery and verification, new drug development, clinical process development, etc. PASS is a platform for integrative analysis of pan-omics data, based on our proven and reliable bioinformatics analysis capabilities. Our team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics. Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable. With PASS, you can leverage Bertis scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.

Exo-PASS Exosomes contain proteins, lipids, nucleic acids, and metabolites, and can be easily enriched from biofluids, providing very valuable information for early detection and monitoring of diseases. The Ministry of Food and Drug Safety requires RNA, lipid and proteomic analyses in its guidelines for the development of exosome therapeutics, and PASS provides these analyses in an all-in-one package. Exosome RNA Sequencing: PASS enables rapid and efficient isolation of RNAs and profiling of exosome nucleic acids using qRT-PCR and novel sequencing methods. Exosome Lipidomics: We perform high-reliability and high-sensitivity analysis through an ultra-high-performance tool (UPLC, Orbitrap Exploris 480 MS) and lipid analysis experts who have been producing and interpreting analysis data for many years. Exosome Proteomics: PASS offers and performs quantification analysis that meets customer needs based on the unique expertise in exosome protein extraction. We provide reliable results through deep profiling of exosome proteome and a specialized data library. Our world-class bioinformatics research team at Bertis reviews and interprets pan-omics data (RNA/Lipid) to support in-depth research.

Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood. High diagnostic accuracy : Quantitative values of biomarkers are measured and entered in a unique algorithm with applied AI. Convenience : No burden of inconvenience caused due to the use of a separate diagnostic device other than blood sampling Efficiency: Provides diagnosis opportunities to more people in situations where personnel and devices are limited

MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm. An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood. Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy and reproducibility among these combinations. DEVELOPMENT PROCESS: - MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University. - After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy, the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy. - After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.

Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment